[{"address1": "12730 High Bluff Drive", "address2": "Suite 400", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 500 8800", "website": "https://kuraoncology.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. Its lead product candidate includes ziftomenib, a selective investigational inhibitor of the menin-KMT2A interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; tipifarnib, an orally bioavailable farnesyl transferase inhibitor combination with alpelisib for patients with PIK3CA-dependent HNSCC; and KO-2806, a selective investigational FTI for the treatment of solid tumors. It has a clinical collaboration with Novartis Pharma AG to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression and/or PIK3CA mutation and/or amplification; strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize its oral menin inhibitor for the treatment of patients with acute myeloid leukemia (AML) and other hematologic malignancies; and a clinical collaboration with Mirati Therapeutics, Inc. to evaluate the combination of KO-2806 and adagrasib, a KRASG12C inhibitor in patients with NSCLC. The company is headquartered in San Diego, California.", "fullTimeEmployees": 192, "companyOfficers": [{"maxAge": 1, "name": "Dr. Troy Edward Wilson J.D., Ph.D.", "age": 55, "title": "Chairman, CEO & President", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 1296258, "exercisedValue": 1234936, "unexercisedValue": 15624}, {"maxAge": 1, "name": "Ms. Kathleen  Ford", "age": 77, "title": "Chief Operating Officer", "yearBorn": 1947, "fiscalYear": 2024, "totalPay": 868935, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Teresa Brophy Bair Esq., J.D.", "age": 53, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 745021, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas  Doyle", "age": 53, "title": "Senior Vice President of Finance & Accounting", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Francis J. Burrows Ph.D.", "age": 62, "title": "Chief Scientific Officer", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Roger  Bakale Ph.D.", "title": "Senior Vice President of Manufacturing & Supply Chain", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Maureen  Clancy M.B.A.", "title": "VP and Global Head of Program Leadership & Project Management", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mollie  Leoni M.D.", "age": 46, "title": "Chief Medical Officer", "yearBorn": 1978, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian T. Powl M.B.A., M.S.", "age": 50, "title": "Chief Commercial Officer", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Samir  Vattompadam M.S.", "title": "Senior Vice President of Global Program Leadership", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 7, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1756684800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.825, "open": 8.82, "dayLow": 8.18, "dayHigh": 8.84, "regularMarketPreviousClose": 8.825, "regularMarketOpen": 8.82, "regularMarketDayLow": 8.18, "regularMarketDayHigh": 8.84, "payoutRatio": 0.0, "beta": 0.19, "forwardPE": -3.0674155, "volume": 1553884, "regularMarketVolume": 1553884, "averageVolume": 1612029, "averageVolume10days": 1801660, "averageDailyVolume10Day": 1801660, "bid": 8.15, "ask": 8.24, "bidSize": 3, "askSize": 1, "marketCap": 710869056, "fiftyTwoWeekLow": 5.41, "fiftyTwoWeekHigh": 21.4, "priceToSalesTrailing12Months": 8.535995, "fiftyDayAverage": 6.87, "twoHundredDayAverage": 7.307675, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 99613944, "profitMargins": -2.36761, "floatShares": 63935674, "sharesOutstanding": 86797200, "sharesShort": 8407325, "sharesShortPriorMonth": 7906891, "sharesShortPreviousMonthDate": 1753920000, "dateShortInterest": 1756425600, "sharesPercentSharesOut": 0.09689999, "heldPercentInsiders": 0.01204, "heldPercentInstitutions": 0.95875, "shortRatio": 4.6, "shortPercentOfFloat": 0.0971, "impliedSharesOutstanding": 93526896, "bookValue": 3.52, "priceToBook": 2.3267045, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -197172000, "trailingEps": -2.25, "forwardEps": -2.67, "enterpriseToRevenue": 1.196, "enterpriseToEbitda": -0.455, "52WeekChange": -0.60757065, "SandP52WeekChange": 0.16885936, "quoteType": "EQUITY", "currentPrice": 8.19, "targetHighPrice": 40.0, "targetLowPrice": 11.0, "targetMeanPrice": 27.0, "targetMedianPrice": 27.0, "recommendationMean": 1.46667, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 11, "totalCash": 630728000, "totalCashPerShare": 7.267, "ebitda": -218828000, "totalDebt": 19473000, "quickRatio": 5.928, "currentRatio": 6.159, "totalRevenue": 83279000, "debtToEquity": 6.374, "revenuePerShare": 0.954, "returnOnAssets": -0.22933, "returnOnEquity": -0.5111, "grossProfits": -114831000, "freeCashflow": -57676124, "operatingCashflow": 124987000, "grossMargins": -1.3788699, "ebitdaMargins": -2.6276503, "operatingMargins": -4.75314, "financialCurrency": "USD", "symbol": "KURA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1757715971, "regularMarketTime": 1757707201, "exchange": "NMS", "messageBoardId": "finmb_282774456", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -7.19547, "regularMarketPrice": 8.19, "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1612029, "fiftyTwoWeekLowChange": 2.7799997, "fiftyTwoWeekLowChangePercent": 0.5138632, "fiftyTwoWeekRange": "5.41 - 21.4", "fiftyTwoWeekHighChange": -13.21, "fiftyTwoWeekHighChangePercent": -0.6172897, "fiftyTwoWeekChangePercent": -60.757065, "earningsTimestamp": 1754596800, "earningsTimestampStart": 1762459200, "earningsTimestampEnd": 1762459200, "earningsCallTimestampStart": 1754598600, "earningsCallTimestampEnd": 1754598600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.25, "epsForward": -2.67, "epsCurrentYear": -2.23256, "priceEpsCurrentYear": -3.6684344, "fiftyDayAverageChange": 1.3199997, "fiftyDayAverageChangePercent": 0.1921397, "twoHundredDayAverageChange": 0.8823247, "twoHundredDayAverageChangePercent": 0.12073946, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "shortName": "Kura Oncology, Inc.", "longName": "Kura Oncology, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1442410200000, "postMarketChangePercent": 1.9414, "postMarketPrice": 8.349, "postMarketChange": 0.159, "regularMarketChange": -0.635, "regularMarketDayRange": "8.18 - 8.84", "displayName": "Kura Oncology", "trailingPegRatio": null, "__fetch_time": "2025-09-13"}]